From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

Compared to thousands of others across the country, Solano County’s local hospitals ranked moderately well, with Kaiser ...

Avalyn Pharma has drawn in another fundraising round, this time a $100 million oversubscribed series D to continue developing ...

With limited treatment options and potential for admission to the intensive care unit, researchers of a new paper highlighted ...

New research from the COPD Foundation and Phreesia shows conversations with healthcare providers can play a critical role in ...

The incidence of pulmonary arterial hypertension (PAH) has increased worldwide over the past three decades, although death ...

Chronic thromboembolic pulmonary hypertension (CTEPH) is the clinical term for high blood pressure in the lungs caused by blockages, such as clots, in the blood vessels. Although CTEPH therapies have ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Christopher Kennedy didn't think anything was wrong. Soon, doctors were telling him a double lung transplant was his only ...

Some of the most interesting data are precisely those illustrating the reality of clinical practice of physicians attending ...

Britain's GSK and China's Jiangsu Hengrui Pharmaceuticals have agreed on a $500 million deal to develop up to a dozen new ...

Management of chronic thromboembolic pulmonary hypertension (CTEPH) includes multimodal therapy that depends on expert centres' experience.1,2 Guidelines advocate for pulmonary endarterectomy (PEA) to ...